Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ANIK logo

ANIK

NGS
Anika Therapeutics Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Monday 7th July 2025
11.25
No Change
Prev Close:11.25
Open:11.27
Bid:10.0
Ask:17.62
52 Week Range
10.47
29.12
Volume:72,634
Mkt Cap:151 M
Price Target
$12.94
+15.0%
Financials

Financial Statements

ANIK - Cash Flow (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Asset Impairment Charge47 M66 M5 M7 M50 M2 M4 M695000.0654000.0907000.0
Capital Expenditure Reported8 M5 M7 M5 M2 M3 M5 M9 M14 M9 M
Cash Flow From Continuing Investing Activities-8 M-5 M-7 M-24 M-100 M40 M-50 M-12 M-7 M-30 M
Change In Account Payable-3 M-11000.02 M-1 M822000.0767000.0-2 M4 M-5 M6 M
Change In Accrued Expense-4 M2 M-443000.04 M-142000.04 M1 M-1 M2 M-199000.0
Change In Income Tax Payable665000.0530000.01 M-1 M-2 M-1 M922000.0367000.0-4 M5 M
Change In Interest Payable-142000.04 M1 M-1 M2 M-199000.0
Change In Payables And Accrued Expense-6 M2 M3 M1 M-1 M3 M564000.03 M-7 M11 M
Change In Prepaid Assets558000.0560000.0-792000.01 M-2 M-2 M899000.0-1 M-898000.089000.0
Change In Tax Payable665000.0530000.01 M-1 M-2 M-1 M922000.0367000.0-4 M5 M
Change In Working Capital-11 M-10 M-10 M-4 M-11 M-6 M-3 M-2 M-16 M3 M
Changes In Account Receivables3 M-1 M-6 M-6216.06 M-2 M3 M3 M-6 M-5 M
Common Stock Payments-11 M-5 M-30 M-30 M-25 M
Depreciation And Amortization10 M16 M14 M14 M13 M7 M6 M4 M4 M4 M
Excess Tax Benefit From Stock Based Compensation-647000.0-847000.0
Financing Cash Flow-13 M-6 M-5 M-7 M-4 M81 M-29 M314000.0-24 M2 M
Gain Loss On Investment Securities-25000.0
Gain Loss On Sale Of PPE3 M2 M993000.0265000.0927000.0152000.0150000.0
Income Tax Paid Supplemental Data4 M3 M106000.01 M993000.09 M6 M15 M23 M13 M
Issuance Of Capital Stock708000.0805000.0665000.0
Issuance Of Debt-284000.0-201000.0-558000.0
Net Business Purchase And Sale-22 M-123 M
Net Common Stock Issuance-10 M-4 M665000.0-30 M-30 M-25 M
Net Intangibles Purchase And Sale-600000.0
Net Investment Properties Purchase And Sale3 M25 M43 M-46 M-3 M7 M-21 M
Net Investment Purchase And Sale3 M25 M43 M-46 M-3 M7 M-21 M
Net Issuance Payments Of Debt-284000.0-201000.0-558000.0
Net Long Term Debt Issuance-284000.0-201000.0-558000.0
Net PPE Purchase And Sale-8 M-5 M-7 M-5 M-2 M-3 M-5 M-9 M-14 M-9 M
Other Non-cash Items59 M79 M19 M14 M54 M7 M16 M8 M4 M2 M
Proceeds From Stock Option Exercised76000.023000.016000.01 M2 M22 M3 M314000.01 M1 M
Purchase Of Intangibles-600000.0
Purchase Of Investment-20 M-104 M-92 M-45 M-39 M-45 M
Purchase Of Long Term Investments-20 M-104 M-92 M-45 M-39 M-45 M
Purchase Of PPE-8 M-5 M-7 M-5 M-2 M-3 M-5 M-9 M-14 M-9 M
Repayment Of Debt-284000.0-201000.0-51 M
Sale Of Business-21 M-29 M
Sale Of Investment3 M45 M146 M46 M42 M47 M24 M
Stock Based Compensation13 M15 M14 M11 M5 M6 M11 M6 M3 M2 M
Amord3 M10 M10 M14 M18 M1 M
Begcash96 M157 M89 M133 M104 M111 M100 M
Capex-8 M-5 M-7 M-5 M-2 M-3 M-5 M-9 M-14 M-9 M
Cffcf-13 M-6 M-5 M-7 M-4 M81 M-29 M314000.0-24 M2 M
Cffinv-8 M-5 M-7 M-3 M-100 M40 M-50 M-12 M-7 M-30 M
Cffoa5 M-2 M4 M36 M42 M37 M35 M41 M24 M39 M
Chgcash-16 M-14 M-8 M-1 M-62 M158 M-44 M29 M-6 M11 M
Chginv-9 M-11 M-7 M-7 M-14 M-6 M-8 M-7 M-2 M-3 M
Chgothcl-708000.016000.0-109000.0
Chgpay-2 M519000.03 M-2 M-1 M-318000.0-749000.04 M-9 M11 M
Chgrec3 M-1 M-6 M-6216.06 M-2 M3 M3 M-6 M-5 M
Comstkiss708000.0805000.0665000.0
Definc260000.0-6 M-5 M-2 M-4 M794000.0-2 M-1 M-65000.0-747000.0
Deftax260000.0-6 M-5 M-2 M-4 M794000.0-2 M-1 M-65000.0-747000.0
Depamor7 M6 M7 M22 M26 M7 M6 M4 M4 M4 M
Effexch-48000.079000.0-130000.069000.0327000.0-133000.029000.0349000.0-138000.0-208000.0
Endcash57 M-13 M-8 M96 M96 M247 M89 M133 M104 M111 M
Fcf-3 M-7 M-3 M3 M40 M34 M30 M32 M10 M30 M
Ltdebtiss50 M
Ltdebtpay-284000.0-201000.0-51 M
Netinccont-56 M-83 M-15 M4 M-24 M27 M19 M32 M33 M31 M
Netothfin-3 M-2 M-5 M-8 M-5 M89 M-2 M647000.0847000.0
Netothinv-29 M
Opcf5 M-2 M4 M8 M42 M37 M35 M41 M24 M39 M
Opgainloss3 M2 M993000.0265000.0902000.0-219000.0150000.0
Purchbus-476000.0-95 M
Purchsti-20 M-104 M
Repurchstk-11 M-5 M-30 M-30 M-25 M
Salesti3 M45 M146 M46 M42 M47 M24 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader